Bank of Nova Scotia’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Bank of Nova Scotia's NVS Position: Q1 2026 in Review
Bank of Nova Scotia reduced its Novartis (NVS) stake by 57% in Q1 2026, selling an estimated $277K and leaving 1,386 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #1025.
Bank of Nova Scotia first reported a position in NVS in Q3 2014 and has held it in 8 quarters since. The position peaked at $4.4M in Q4 2015. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Bank of Nova Scotia held 1,386 shares of Novartis worth $212K as of Q1 2026.
- Bank of Nova Scotia sold 1,809 Novartis shares in Q1 2026, an estimated $277K.
- Novartis made up ﹤0.01% of Bank of Nova Scotia's portfolio in Q1 2026, its #1025 holding.
- Bank of Nova Scotia first reported a position in Novartis in Q3 2014 and has held it in 8 quarters since.
- Bank of Nova Scotia's Novartis position peaked at $4.4M in Q4 2015.
- 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.